Barriers to genetic testing for patients with cancer may vary based on demographics and other personal factors, a pilot project associated with a large clinical trial found. In a University of Michigan study, women, for instance, were more likely to report worries about the implications of their test results for family members and how their results could affect their health and life insurance.